Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

NCT00987493

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • St. Claraspital AG Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View all 16 locations
View Trial Details
Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00392691

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

NCT00544219

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • European Institute of Oncology Milan, Italy
  • Hirslanden Klinik Aarau Aarau, Switzerland
  • Kantonspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
View all 19 locations
View Trial Details
Completed

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)

NCT02549651

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Albuquerque, New Mexico, United States
  • Research Site Durham, North Carolina, United States
View all 13 locations
View Trial Details
Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details

Related conditions